title: Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.forename: James A
authors.initials: JA
authors.lastname: Goldstein
authors.forename: Robert D
authors.initials: RD
authors.lastname: Safian
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D002317:Cardiovascular Agents / Q000008:administration & dosage; D054855:Drug-Eluting Stents; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D018570:Risk Assessment; D012720:Severity of Illness Index; D020123:Sirolimus / Q000008:administration & dosage; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; D017239:Paclitaxel; D020123:Sirolimus